Supramarginal investigates whether the chances of survival in glioblastoma increase by removing extra tissue around the tumor during surgery.

The Supramarginal study aims to determine whether survival rates in glioblastoma improve by removing tissue around the tumor that appears to be normal.

This surgery can only be performed on patients with small tumors that are localized and operable. The risk is that neurological and/or cognitive functions could be damaged, so this needs to be taken into consideration before treatment. 

Asgeir Jakola is a senior physician and professor at the University of Gothenburg and is involved in leading the Supramarginal study.

More information about Supramarginal

Supramarginaltrial.com